These results suggested that FGF17 may partly influence glutamine synthesis, and that cisplatin exerts its antitumor effect, at least in part, by modulating glutamine metabolism in tumor cells, with this effect amplified by FGF17 silencing. Here, FGF17 is linked to neoplasm.